MedTrace Logo

Using Social Media to Improve ART Retention and Treatment Outcomes Among YLHIV in Nigeria

NCT03516318 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 355

Last updated 2020-04-13

No results posted yet for this study

Summary

A randomized control trial to test the effectiveness of a structured online support group, SMART (Social Media to improve ART Retention in Treatment) Connections, to improve retention in HIV care services among youth living with HIV (YLHIV) in Nigeria.

Conditions

  • Human Immunodeficiency Virus

Interventions

BEHAVIORAL

SMART Connections

SMART Connections: Trained facilitators will deliver key informational messages and moderate online group discussions. The informational messages have been developed from key messages identified in each of the Positive Connections curriculum sessions. Each SMART Connections group will consist of approximately 15 to 20 YLHIV. Each online support group will begin with one in-person group meeting with the facilitator. During this meeting, participants meet one another and the facilitators. Facilitators will describe the intervention and set ground rules for participation. Ground rules will be discussed and accepted by the group members, but at a minimum, group members will be advised not to talk about what is discussed in the online group with people outside of the group.

Sponsors & Collaborators

  • Center for Population and Reproductive Health, University of Ibadan

    collaborator UNKNOWN

  • FHI 360

    lead OTHER

Principal Investigators

  • Lisa S Dulli, PhD · FHI 360 (Family Health International)

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-04
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03516318 on ClinicalTrials.gov